Notification of changes to Histology Staining

on Thursday, 24 August 2017. Posted in Cellular Pathology, General

Haematoxylin and eosin platform change.

We are changing our platform for the haematoxylin and eosin stain used for all routine histopathology cases to the Roche HE600 platform from Monday 4th September 2017. This is to allow us to improve the workflow and traceability of reagents used.

The existing platform will remain in use as contingency and for macro slide staining.

During slide review at MDT meetings you may notice a difference in the tone of the staining.
This new platform will be assessed by UKAS against ISO 15189 standards at our next annual inspection in October.

For further information about this change please contact the department on 0121 424 3188 and ask to speak to a senior member of staff.

Leave a comment

Please login to leave a comment.

Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018

HTA licence number is 12366

Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.

The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS Logos